?

Adarsh Gopinathan, a 必威体育betway888 Scholar (ICMR-SRF) in the Department of Pharmacology at 必威体育betway888 College of Pharmaceutical Sciences (MCOPS), 必威体育betway888, has been awarded a travel grant under the Science and Engineering 必威体育betway888 Board (SERB) 必威体育betway888 Travel Support (ITS) Scheme. This grant will support him in attending the Brain Tumour Conference organized by Cancer 必威体育betway888 UK in London, UK, from 24 to 26 September 2024. The grant covers the airfare, visa charges, and registration fees for the conference.

At the Brain Tumour Conference, Adarsh will be presenting his research on upregulation of neprilysin via HDAC1 inhibition to treat glioblastoma. Mr. Adarsh is doing his PhD under the guidance of Dr. Anoop Kishore, Associate Professor, Department of Pharmacology at MCOPS, MAHE, 必威体育betway888, and the Co-guide is Dr. K. Sreedhara Ranganath Pai, Professor in the Department of Pharmacology at MCOPS, MAHE, 必威体育betway888.

Congratulations to Adarsh for this remarkable achievement !!

#DSTSERB, #必威体育betway888 Travel Support, #HDAC, #Glioblastoma, #Neprilysin, #Cancer, #conference.